AI: DeepSeek (deepseek-chat)

Q: {
  "guidelineId": "cg1127-neonatal-abstinence-scoring-pdf",
  "fieldsProcessed": [
    "humanFriendlyName",
    "organisation",
    "yearProduced",
    "summary"
  ],
  "enhancedFields": 4,
  "contentLength": 6543
}

A: {
  "success": true,
  "enhancedFields": [
    {
      "field": "humanFriendlyName",
      "oldValue": null,
      "newValue": "Neonatal Abstinence Syndrome Assessment and Management",
      "action": "added"
    },
    {
      "field": "organisation",
      "oldValue": null,
      "newValue": "The text does not explicitly mention a specific publishing organization or institution like NHS, NICE, WHO, RCOG, etc. Therefore, I cannot identify a specific organization name from the provided guideline text",
      "action": "added"
    },
    {
      "field": "yearProduced",
      "oldValue": null,
      "newValue": "The text provided does not contain a publication year. If you have another guideline text that includes the year, please share it, and I can extract the 4-digit year for you",
      "action": "added"
    },
    {
      "field": "summary",
      "oldValue": null,
      "newValue": "**Summary of Neonatal Abstinence Syndrome (NAS) Guideline** **Scope**: Applies to pediatric, neonatal, and midwifery staff caring for newborns at risk of NAS due to maternal substance use. **Key Responsibilities**: - Staff must follow guidelines, use professional judgment, and ensure accessibility. - Monitor for withdrawal symptoms using scoring tools. **Substance Effects**: - **Opiates**: Risk of premature birth, low birth weight; avoid pethidine/diamorphine in labor. - **Benzodiazepines**: Withdrawal may occur late (10 days–6 weeks); treat with chlorpromazine. - **Alcohol**: Phenobarbitone may be needed. - **Others**: Cannabis (mild symptoms), cocaine (placental abruption), nicotine (low birth weight). **Management**: - **Antenatal**: Counsel parents, refer to social services, offer Hepatitis B vaccine if needed. - **Postnatal**: Observe for ≥2 days; keep parent and baby together. - **Pharmacological Treatment**: - **Opiate withdrawal**: Start morphine (125 mcg/kg/day); wean based on NAS scores. - **Non-opiate withdrawal**: Phenobarbitone (alcohol), chlorpromazine (benzodiazepines). **Discharge Criteria**: Stable NAS scores, normal feeding/sleeping, no morphine changes for 36 hours. Ensure social support and follow-up. **Patient Information**: Provide counseling and leaflets on NAS monitoring. **Audit**: Ensure compliance with antenatal plans, NAS scoring, and discharge protocols",
      "action": "added"
    }
  ]
}